Category: Healthcare
-
Date:
Paresthesia Treatment Market to Reach US$ 8.0 Bn by 2034, Led by Pfizer, GlaxoSmithKline, and Eli Lilly
The global paresthesia treatment industry was valued at USD 5.4 billion in 2023. The market is anticipated to expand at a CAGR…
-
Date:
Opioid Use Disorders Market to Reach US$ 8.8 Billion by 2034 Driven by Rising Addiction Cases and Expansion of Medication-Assisted Treatment Programs
The global opioid use disorders market is witnessing substantial growth, fueled by increasing awareness regarding substance abuse disorders and growing adoption of…
-
Date:
Oral Solid Dosage Pharmaceutical Formulation Market to Reach US$ 1.1 Billion by 2034, Driven by Rising Patient Compliance and Growing Demand for Convenient Drug Delivery Systems
Oral Solid Dosage Pharmaceutical Formulation Market Overview Oral solid dosage pharmaceutical formulations include tablets, capsules, powders, and other solid oral medications designed…
-
Date:
PCSK9 Inhibitor Market Expected to Reach USD 9.3 Billion by 2034 as Rising Cardiovascular Disease Burden Fuels Demand for Advanced Cholesterol-Lowering Therapies
The global PCSK9 inhibitor market is poised for remarkable expansion over the next decade, driven by the growing prevalence of high cholesterol…
-
Date:
Non-Hodgkin’s Lymphoma Therapeutics Market Size Forecast to USD 18.6 Billion by 2034 with Growing Adoption of Targeted Cancer Therapies – Analysis by Transparency Market Research
According to recent market analysis, the global non-Hodgkin’s lymphoma therapeutics industry was valued at US$ 8.0 billion in 2023 and is anticipated…
-
Date:
Non-insulin Therapies for Diabetes Market to Reach USD 58.6 Billion by 2034, Driven by Rising Type 2 Diabetes Prevalence and Expanding Therapeutic Innovations
The global non-insulin therapies for diabetes market is poised for substantial growth over the next decade as healthcare systems worldwide intensify efforts…
-
Date:
Nocturia Market to Reach USD 8.5 Billion by 2034, Led by Key Players Such as Ferring Pharmaceuticals, Astellas Pharma, and Pfizer
The global Nocturia market was valued at USD 3.7 billion in 2023 and is projected to reach USD 8.5 billion by the…
-
Date:
Myocarditis Treatment Market to Reach US$ 2.7 Billion by 2034, Driven by Rising Cardiovascular Disease Burden and Advancements in Early Diagnosis Technologies
Myocarditis Treatment Market Overview Myocarditis is an inflammatory condition affecting the heart muscle (myocardium), often caused by viral infections, autoimmune diseases, bacterial…
-
Date:
Natural APIs Market Revenue to Exceed USD 57.5 Billion by 2034 Amid Growing Herbal Drug Adoption
The Natural APIs Market is witnessing substantial growth due to increasing demand for naturally derived medicines, growing consumer preference for plant-based healthcare…
-
Date:
Neuroregeneration Therapy Market to Reach USD 64.8 Billion by 2034, Driven by Rising Neurological Disorders and Advancements in Regenerative Medicine
The global neuroregeneration therapy market is witnessing significant growth as healthcare systems worldwide focus on addressing the rising burden of neurological disorders.…
Olivia
Carter
is a writer covering health, tech, lifestyle, and economic trends. She loves crafting engaging stories that inform and inspire readers.
